Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L. Nguyen, Benjamin G. Bitler|Molecular Cancer Therapeutics|2024Cited by 11
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant modelsLily L. Nguyen, Benjamin G. Bitler|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1